Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3256 AL 3270

Cerebrovascular pathology in Alzheimer's disease: Hopes and gaps

Badji A, Westman E.

Psychiatry Res Neuroimaging. 2020 Dec 30;306:111184. doi: 10.1016/j.pscychresns.2020.111184. Epub 2020 Sep 7.

Challenges in demonstrating the value of disease-modifying therapies for Alzheimer's disease

Gustavsson A, Pemberton-Ross P, Gomez Montero M, Hashim M, Thompson R.

Expert Rev Pharmacoecon Outcomes Res. 2020 Dec;20(6):563-570. doi: 10.1080/14737167.2020.1822738. Epub 2020 Sep 20.

Neprilysin expression and functions in development, ageing and disease

Nalivaeva NN, Zhuravin IA, Turner AJ.

Mech Ageing Dev. 2020 Dec;192:111363. doi: 10.1016/j.mad.2020.111363. Epub 2020 Sep 26.

Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation

Liu Y, Li H, Wang J, Xue Q, Yang X, Kang Y, Li M, Xu J, Li G, Li C, Chang HC, Su KP, Wang F.

JAMA Netw Open. 2020 Oct 1;3(10):e2018777. doi: 10.1001/jamanetworkopen.2020.18777.

The Dual Role of Glutamatergic Neurotransmission in Alzheimer's Disease: From Pathophysiology to Pharmacotherapy

Bukke VN, Archana M, Villani R, Romano AD, Wawrzyniak A, Balawender K, Orkisz S, Beggiato S, Serviddio G, Cassano T.

Int J Mol Sci. 2020 Oct 9;21(20):7452. doi: 10.3390/ijms21207452.

β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification

Hampel H, Lista S, Vanmechelen E, Zetterberg H, Giorgi FS, Galgani A, Blennow K, Caraci F, Das B, Yan R, Vergallo A; Alzheimer’s Precision Medicine Initiative (APMI).

Alzheimers Res Ther. 2020 Oct 16;12(1):130. doi: 10.1186/s13195-020-00686-3.

Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer's Disease

Atlante A, Amadoro G, Bobba A, Latina V.

Cells. 2020 Oct 23;9(11):2347. doi: 10.3390/cells9112347.

CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment

Gaetani L, Paolini Paoletti F, Bellomo G, Mancini A, Simoni S, Di Filippo M, Parnetti L.

Trends Pharmacol Sci. 2020 Dec;41(12):1023-1037. doi: 10.1016/j.tips.2020.09.011. Epub 2020 Oct 27.

Applications of iTRAQ and TMT Labeling Techniques to the Study of Neurodegenerative Diseases

Li K, Chen Z, Zhang Y, Yang X.

Curr Protein Pept Sci. 2020;21(12):1202-1217. doi: 10.2174/1389203721666201103085704.

Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer's Disease

Arastoo M, Lofthouse R, Penny LK, Harrington CR, Porter A, Wischik CM, Palliyil S.

Int J Mol Sci. 2020 Nov 17;21(22):8673. doi: 10.3390/ijms21228673.

Sigma-2 Receptor-A Potential Target for Cancer/Alzheimer's Disease Treatment via Its Regulation of Cholesterol Homeostasis

Yang K, Zeng C, Wang C, Sun M, Yin D, Sun T.

Molecules. 2020 Nov 20;25(22):5439. doi: 10.3390/molecules25225439.

Pharmacogenetic studies in Alzheimer disease

Zúñiga Santamaría T, Yescas Gómez P, Fricke Galindo I, González González M, Ortega Vázquez A, López López M.

Neurologia (Engl Ed). 2022 May;37(4):287-303. doi: 10.1016/j.nrleng.2018.03.022. Epub 2020 Jun 1.

NF-κB as a Key Mediator of Brain Inflammation in Alzheimer's Disease

Ju Hwang C, Choi DY, Park MH, Hong JT.

CNS Neurol Disord Drug Targets. 2019;18(1):3-10. doi: 10.2174/1871527316666170807130011.

Neuroprotective Effects of Flavonoid Compounds on Neuronal Death Associated to Alzheimer's Disease

Sureda A, Capó X, Tejada S.

Curr Med Chem. 2019;26(27):5124-5136. doi: 10.2174/0929867325666171226103237.

Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer's Disease: A Systematic Review

da Costa IM, Freire MAM, de Paiva Cavalcanti JRL, de Araújo DP, Norrara B, Moreira Rosa IMM, de Azevedo EP, do Rego ACM, Filho IA, Guzen FP.

Curr Neuropharmacol. 2019;17(5):406-421. doi: 10.2174/0929867325666180117112610.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias